DEA Compliance 1 (DC1) is a DEA compliance focused consulting and risk mitigation organization which focuses on pain and prescription opioids, pharmacy and Ambulatory Surgery Center (ASC) operations, SAMHSA Medication Assisted Treatment (MAT) and Opioid
A June deadline from the Biden Administration demanding that medical doctors who prescribe opioids qualify for a DEA license to do so by taking 8 hours of training has drawncritical commentsfrom the many doctors affected: So if I understand this correctly, the new requirement applies to DEA regi...
"The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop, Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain." Annals of Internal Medicine N/A (N/A): N/A – N/A. ...